Infliximab (Remicade) for Patients With Acute Kawasaki Disease
NCT00271570
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Kawasaki Disease
Interventions
DRUG:
Infliximab (Remicade)
BIOLOGICAL:
Intravenous immunoglobulin (IVIG)
Sponsor
University of California, San Diego
Collaborators
[object Object]